Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gimv NV Earnings Release 2016

May 18, 2017

3956_er_2017-05-18_121777e6-1030-41ce-8cbf-f52133c9f3b1.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Antwerp, 18 May 2017, 7:00 CET (embargo)

Important divestments plus strong operational performance by investee companies produce excellent portfolio return of 19% and net profit of EUR 131.9 million

Strong pace of investment with 11 new investments (EUR 179.6 million)

Gross dividend grows to EUR 2.50

Managing Director Koen Dejonckheere, on the past financial year's results: "The past year was another intense and successful year for Gimv. We invested in 11 promising new companies, across all our investment platforms, for a total of EUR 180 million. At the same time, market conditions remained favourable, permitting 12 exits with a positive impact on income. This result was also buoyed by the strong performance of investee companies. Our active investment approach, together with the significant value creation in our portfolio, enabled us to post a strong result for the 2016-2017 financial year. The 19 percent portfolio yield translates into a net profit of EUR 132 million."

Chairman Hilde Laga adds: "The sector-oriented platform strategy we opted for as well as the financial, strategic and industrial expertise built up in this way strengthens our investment approach aimed at sustainable long-term value creation. The specializations built over the years allowed us last year to continue to invest actively, in what is a very competitive market, which strengthens our confidence in our ability to advance vigorously into the future. "

The results for the 2016-2017 financial year cover the period from 1 April 2016 to 31 March 2017.

Highlights (consolidated figures)

  • Results supported by strong portfolio result for the 3rd consecutive year.
  • o Solid sales and EBITDA growth in the large majority of the shareholdings
  • o Record amount of divestments with attractive capital gains
  • o Return on equity of 11.0%
  • Strong pace of investment continues
  • o 51 shareholdings in portfolio, of which 11 were added during the past financial year

Results

  • Net result (group's share) EUR 131.9 million (EUR 5.19 per share)
  • Net realised capital gains: EUR 84.3 million
  • Net unrealised capital gains: EUR 55.7 million

Equity (at 31.03.2017)

Equity value (group's share): EUR 1,233.2 million (EUR 48.50 per share)

Balance sheet (at 31.03.2017)

  • Balance sheet total: EUR 1,315.3 million
  • Investment Portfolio: EUR 963.6 million
  • Net cash position: EUR 313.9 million (EUR 250.3 million when taking into account the planned dividend payment)

Investments

Total investments (on balance sheet): EUR 179.6 million

Divestments

  • Total divestment revenues (on balance sheet): EUR 394.3 million
  • Divestment revenues: 2,3x their investment cost and 26.9% above their value in equity at 31 March 2016.

Dividend

  • Dividend for FY 2016-2017 rises to EUR 2.50 gross (EUR 1.75 net) per share (subject to approval by the General Meeting of 28 June 2017)
  • This year we have opted for a 100% cash dividend

Explanation of the figures (consolidated figures) 1

Strong annual result of EUR 131.9 million

For FY 2016-2017 Gimv posted a net profit (group share) of EUR 131.9 million, compared with a net profit of EUR 137.2 million in FY 2015-2016. More than half of this result consists of the realised capital gains on the divestments of the past year, and the balance of the unrealised capital gains on the portfolio.

Net realised capital gains during FY 2016-2017 amounted to EUR 84.3 million (2015-2016: EUR 70.5 million). 88% of these net capital gains were realised in the four investment platforms, with all platforms making a positive contribution. Smart Industries contributed EUR 51.2 million, followed by Connected Consumer with EUR 11.4 million, Health & Care with EUR 6.3 million and Sustainable Cities with EUR 5.4 million. Finally, EUR 9.9 million of capital gains were realised on the distributions from on third party funds and the sale of the shareholding in the listed Capman entity.

Net unrealised capital gains totalled EUR 55.7 million (vs. EUR 88.7 million in FY 2015-2016), coming mainly from Sustainable Cities (EUR 22.9 million) and Connected Consumer (EUR 21.8 million). But Smart Industries (EUR 14.1 million) and Health & Care (EUR 7.4 million) also made positive contributions. The third-party funds and other shareholdings, on the other hand, delivered a negative contribution (EUR -10.5 million).

The net unrealised capital gains are a direct consequence of the application of the prevailing international private equity valuation rules. On the one hand, these net unrealised capital gains are due primarily to a number of positive elements: (i) a decrease in net financial debt in the shareholdings (EUR 20.8 million), (ii) the increased share price of a number of listed shareholdings (EUR 16.6 million), (iii) the better results at the majority of shareholdings (EUR 15.2 million), (iv) the first revaluation of a number of shareholdings (EUR 12.7 million), (v) the upcoming sale of the shareholding in Teads (EUR 4.5 million), (vi) increased multiples (EUR 3.1 million), and (vii) positive exchange rate effects (EUR 0.1 million). On the other hand, there were also a number of negative elements: (viii) an impairment loss (EUR -9.2 million), (ix) a decrease in the value of the third-party funds (EUR -3.1 million) and (x) a number of minor value adjustments2 (combined effect of EUR -5.1 million).

The other operating result for FY 2016-20173 came out at EUR 11.5 million, compared with EUR - 8.5 million in FY 2015-2016. On the one side, the other operating income increased by threequarters (EUR 59.2 million vs. EUR 33.5 million), mainly due to an increase in dividends received (EUR +27.2 million). On the other side, other operating expenses (including transaction costs) increased only slightly (EUR 47.7 million versus 42.0 million).

The net financial result for the year is EUR 1.7 million positive, in line with 2015-2016 (EUR 1.8 million).

1 All income statement-related figures are compared with the figures for the 2015-2016 financial year. Balance-sheet related figures are compared with the situation at 31 March 2016.

2 This reduction in value is primarily due to the payment of a dividend by Gimv-XL Partners.

3 Dividends, interest, management fees, turnover and other operating income, after deducting services and other goods, personnel costs, amortization of intangible fixed assets, depreciation of land, buildings and equipment, and other operating costs.

After deducting taxes (EUR -3.5 million) and non-controlling interests (EUR -17.8 million), Gimv realised for the 2016-2017 financial year a net profit (group share) of EUR 131.9 million.

Active investment year

In FY 2016-2017, Gimv made in all EUR 179.6 million of on-balance sheet investments (EUR 130.2 million in FY 2015-2106). An additional EUR 16.2 million were also invested via the co-investment funds (as minority interests), bringing the total investments (on balance sheet and via the coinvestment funds) to EUR 195.8 million (EUR 162.5 million in FY 2015-2016). The past financial year saw significant investments in the various investment platforms. The Smart Industries portfolio expanded with investments in ALT Technologies, Arplas, MEGA International and Summa. In addition, first-time investments were made in Acceo (Sustainable Cities), Breath Therapeutics, EndoStim, G-Therapeutics and Spineart (for the Health & Care platform), and Joolz and Real Impact Analytics (for Connected Consumer). There were also follow-on investments in, among others, Biom'Up, Brakel, Ecochem, Europlasma, Itineris, Jenavalve, OTN, TINC and Topas Therapeutics.

FY2016-2017 FY2015-2016
Investments EUR mio % EUR mio %
Connected Consumer 26,0 15% 13,3 10%
Health & Care 34,3 19% 18,6 14%
Smart Industries 66,2 37% 7,4 6%
Sustainable Cities 33,8 19% 82,4 63%
Third party funds 7,9 4% 7,4 6%
Other participations (incl. infra) 11,4 6% 1,1 1%
Total investments 179,6 100% 130,2 100%
FY2016-2017 FY2015-2016
Investments EUR mio % EUR mio %
Direct Investments 171,7 96% 122,8 94%
New investments 137,4 77% 105,4 81%
Follow-on investments 34,3 19% 17,4 13%
Third party funds 7,9 4% 7,4 6%
Total investments 179,6 100% 130,2 100%

Record divestments

In 2016-2017, Gimv sold its shares, among others, in Altaïr/Brunel, Biodiesel Holding (Bioro), BMC, GreenPeak, Hecht, Lampiris, Leyton, Multiplicom, Nomadesk, Onedirect, Punch Powertrain and Vandemoortele. Added to these were a large number of distributions from the third party funds. For these divestments Gimv received in all EUR 394.3 million (227.2 million in 2015-2016). Additional divestments via the co-investment funds (minority interests) added a further EUR 313.5 million (EUR 76.3 million in 2015-2016), bringing total divestments (on balance sheet and via coinvestment funds) to EUR 707.8 million (EUR 303.5 million in 2015-2016).

On top of the sales proceeds of EUR 394.3 million, the sold shareholdings generated during FY 2016-2017 EUR 1.7 million of dividends, interest and management fees. In this way, sold shareholdings produced a total of EUR 396.0 million. On 31 March 2016 these divestments were carried at a total value of EUR 312.1 million. Consequently, the sales generated 26.9% more (EUR 83.9 million) than their carrying value at 31 March 2016 (measured at fair value in the consolidated figures). Over the entire period the realised money multiple on these sold shareholdings was 2.3x (i.e. versus their investment cost).

Divestments FY2016-2017 FY2015-2016
EUR mio % EUR mio %
Connected Consumer 119,5 30% 37,9 17%
Health & Care 8,3 2% 37,1 16%
Smart Industries 163,1 41% 98,3 43%
Sustainable Cities 25,8 7% 9,1 4%
Third party funds 62,9 16% 38,2 17%
Other participations (incl. infra) 14,8 4% 6,5 3%
Total divestments 394,3 100% 227,2 100%
Divestments FY2016-2017 FY2015-2016
EUR mio % EUR mio %
Listed shareholdings 6,2 1% 28,0 12%
Unlisted shareholdings 282,5 72% 143,6 63%
Third party funds 62,9 16% 38,2 17%
Loans 42,6 11% 17,4 8%
Total divestments 394,3 100% 227,2 100%

Portfolio represents three quarters of total assets

Total assets amounted at 31 March 2017 to EUR 1,315.3 million. The portfolio amounts to EUR 963.6 million compared with EUR 1,013.9 million at 31 March 2016. The decrease in the total portfolio is relatively limited, especially taking into account the important level of divestments. This is explained by the EUR 179.6 million of new investments, in addition to the rise in value of the existing shareholdings in the portfolio.

Portfolio FY2016-2017 FY2015-2016
% EUR mio %
Connected Consumer 224,0 23% 281,5 28%
Health & Care 130,3 14% 93,8 9%
Smart Industries 184,3 19% 208,2 20%
Sustainable Cities 186,4 19% 150,1 15%
Third party funds 172,9 18% 210,8 21%
Other participations (incl. infra) 65,8 7% 69,5 7%
Total portfolio 963,6 100% 1.013,9 100%
Portfolio FY2016-2017 FY2015-2016
% EUR mio %
Listed shareholdings 53,9 6% 39,4 4%
Unlisted shareholdings 851,4 88% 919,6 91%
Valuation on the basis of multiples 443,0 46% 416,1 41%
Valuation at investment cost 147,5 15% 142,3 14%
Valuation based on the price established in the most recent financing round 31,3 3% 9,2 1%
Valuation based on the net asset value of the underlying private-equity funds 172,9 18% 210,8 21%
Valuation based on the net asset value of the underlying funds managed by Gimv* 21,8 2% 29,8 3%
Valuation based on other methods (including expected sales value) 34,9 4% 111,4 11%
Loans 58,3 6% 54,9 5%
Total portfolio 963,6 100% 1.013,9 100%

* Excluding Gimv's part in Gimv-XL, Gimv Health & Care and Gimv Arkiv Technology Fund

Portfolio FY2016-2017 FY2015-2016
EUR mio % EUR mio %
Europe 930,7 96% 976,4 96%
Belgium 303,2 31% 393,0 39%
France 193,3 20% 198,3 20%
Germany 118,4 12% 106,9 10%
Netherlands 237,6 25% 194,0 19%
Other European countries 78,3 8% 84,2 8%
RoW 32,9 4% 37,5 4%
Total portfolio 963,6 100% 1.013,9 100%

Net cash position amounts to a quarter of total assets

Gimv's net cash position at the end of March 2017 is EUR 313.9 million, compared with EUR 183.94 million at 31 March 2016. This increase is explained by the significant divestments in the first half of the year.

Equity rises further to EUR 1,233.2 million or EUR 48.50 per share

Equity (group's share) (= net asset value) amounted at 31 March 2017 to EUR 1,233.2 million (EUR 48.50 per share), as against EUR 1,167.9 million (EUR 45.93 per share) at 31 March 2016. The increase in equity during FY 2016-2017, combined with the dividends of EUR 62.3 million paid out during the financial year, represents an economic return on equity for the financial year of 11.0%, in line with Gimv's long-term return.

Gross dividend rises to EUR 2.50 per share (net EUR 1.75).

The Board decided on 16 May 2017 to propose to the annual general meeting of 28 June 2017 to pay a gross dividend of EUR 2.50 per share (up from EUR 2.45 per share). Based on the closing price on 15 May 2017 (EUR 56.36), this represents a gross dividend yield of 4.4%.

This dividend is consistent with the Gimv's dividend policy of not lowering the dividend, except in exceptional circumstances, and of increasing it in a sustainable manner whenever possible.

This year we have opted for a 100% cash dividend. If the General Meeting approves this dividend proposal, the dividend will be paid out on 5 July 2017.

Gimv will in this way have paid out over the past financial year dividends totalling EUR 63.6 million.

Main events since 31 March 2017

  • Shortly before the end of the quarter, it was announced that an agreement had been reached with Altice for the acquisition of online video advertising specialist Teads, in which Gimv has a small shareholding. The transaction is expected to be completed later this month.
  • Earlier this month, Gimv invested EUR 5 million in the French immuno-oncology start-up ImCheck Therapeutics (www.imchecktherapeutics.com), which focuses on developing new antibodies that activate the immune system against various cancers. This investment is part of a total EUR 20 million investment round by a syndicate of specialized life sciences investors.
  • Earlier this month, Gimv also took a significant interest in MVZ Holding AG, a leading group of Swiss medical practices. Gimv has also committed to provide additional capital for the group's further expansion in Switzerland.
  • Recently it was decided that Mr. Tom Van de Voorde will join the Executive Committee as head of the Smart Industries platform. Tom (°1971) started at Gimv in 2007. Prior to that, he worked as Head of M&A at NIBC Advisory and before that as Deputy Director of Investment Banking & Private Equity at Bank Degroof. Tom holds a Master's Degree in Commercial Engineering, as well as an MBA.

4 Cash and cash equivalents of EUR 192.8 million, corrected for advance payments to be paid from divestments

Statement of Risk

  • The results of our businesses and the value development of the portfolio remain dependent on a number of external factors. These include (i) the continuing recovery in Europe's economy and the strength of this recovery, (ii) the further economic developments in emerging markets, (iii) the recovery of confidence by governments, savers and consumers, hampered by ageing, budgetary measures and inflationary pressure, (iv) the geopolitical climate in various regions of the world, (v) the stability of the regulatory environment and the tax treatment of entrepreneurial risk-taking in the markets in which Gimv and our businesses operate, (vi) the stability and liquidity of the financial system, both in terms of valuation levels and for the financing of our companies, (vii) market receptivity to new IPOs and capital transactions, (viii) the appetite of international groups and industry players for further acquisitions, and (ix) the duration and modalities of the liquidity creation programmes of both the FED and the ECB, and thus the room for further impulses for growth, which can have a major impact on financial markets. We must also keep in mind that a number of sectors are facing disruptive development, which brings huge challenges of adapting to them, but at the same time also provides opportunities for companies to reinvent themselves. Assessing the impact of all these factors for the coming period is therefore particularly difficult.
  • Risk management data is available in our annual report, which is available on www.gimv.com.

Financial calendar

General shareholders' meeting in respect of FY 2016-2017 28 June 2017
Ex-date of the 2016-2017 dividend (coupon no. 24) 3 July 2017
Record date of the 2016-2017 dividend (coupon no. 24) 4 July 2017
Payment date of the 2016-2017 dividend (coupon no. 24) 5 July 2017
Business update first quarter FY 2017-2018 (01.04.17-30.06.17) 20 July 2017
Announcement of first half FY 2017-2018 results (01.04.17-30.09.17) 23 November 2017

Principal paying agent for the FY 2016-2017 dividend is: KBC Bank, Havenlaan 2, 1080 Brussels.

Statement by responsible company officers pursuant to the Royal Decree of 14 November 2007

Pursuant to article 13 § 2,3 of the Royal Decree of 14 November 2007, CEO Koen Dejonckheere and CFO Kristof Vande Capelle declare, on behalf of and for the account of Gimv that, as far as is known to them,

a) the consolidated financial statements have been drawn up in accordance with the International Financial Reporting Standards (IFRS) as adopted in the European Union and that they give a true and fair view of the equity and financial situation of the Group at 31 March 2017, and of its results and cash flows for the financial year ending on that date.

b) the annual report gives a true and fair view of the development and results of the Group, as well as a description of the main risks and uncertainties with which it is confronted.

Statement by the Statutory Auditor concerning the accounting data given in the Gimv NV annual press release

The statutory auditor, Ernst & Young Bedrijfsrevisoren BCVBA, represented by Mr Ömer Turna, has delivered an unqualified opinion in respect of the statutorily consolidated financial statements. The statutory auditor has confirmed that the financial data included in the present release do not contain any unmistakable inconsistencies with the consolidated financial statements for the financial year.

Antwerp, 16 May 2017

Ernst & Young Bedrijfsrevisoren BCVBA Auditor represented by

Ömer Turna Partner*

* acting on behalf of a BVBA

For further information, please contact:

Kristof Vande Capelle, Chief Financial Officer T +32 3 290 22 17 – [email protected]

Frank De Leenheer, Investor Relations & Corporate Communications Manager T +32 3 290 22 18 – [email protected]

Appendices:

    1. Gimv Group Consolidated balance sheet at 31 March 2017
    1. Gimv Group Consolidated income statement for the 12 months to 31 March 2017
    1. Gimv Group Statement of changes in consolidated equity for the twelve months to 31 March 2017
    1. Gimv Group Consolidated cash flow statement for the twelve months to 31 March 2017

Appendix 1: Gimv Group – Consolidated balance sheet at 31 March 2017

Gimv Group - Consolidated balance sheet (in EUR 000) 31/03/2017 31/03/2016
I. Non-current assets 972.701 1.023.548
1. Goodwill and other intangible assets 495 630
2. Property, plant and equipment 8.620 9.024
3. Financial assets at fair value through P&L 844.600 888.536
4. Loans to portfolio companies 118.985 125.358
5. Other financial assets - -
II. Current assets 342.560 206.781
6. Trade and other receivables 23.134 12.000
7. Loans to portfolio companies - -
8. Cash and cash equivalents 292.068 192.031
9. Marketable securities and other instruments 21.838 744
10. Other current assets 5.520 2.006
Total assets 1.315.260 1.230.329
Gimv Group - Consolidated balance sheet (in EUR 000) 31/03/2017 31/03/2016
I. Equity 1.278.921 1.195.074
A. Equity attributable to equity holders of the parent 1.233.177 1.167.887
1. Issued capital 241.365 241.365
2. Share premium account 51.629 51.629
3. Retained earnings 940.183 874.893
B. Non-controlling interest 45.744 27.187
II. Liabilities 36.339 35.254
A. Non-current liabilities 18.257 12.309
4. Pension liabilities - -
5. Provisions 17.636 11.415
6. Deferred taxes 620 895
B. Current liabilities 18.083 22.945
7. Financial liabilities - -
8. Trade and other payables 12.754 18.235
9. Income tax payables 179 1.039
10. Other liabilities 5.149 3.670
Total equity and liabilities 1.315.260 1.230.329

Appendix 2: Gimv Group – Consolidated income statement for the 12 months to 31 March 2017

Gimv Group - Consolidated income statement (in EUR 000) 31/03/2017 31/03/2016
1. Operating income 271.813 266.897
1.1. Dividend income 42.810 15.582
1.2. Interest income 8.209 10.623
1.3. Gain on disposal of investments 88.085 74.506
1.4. Unrealised gains on financial assets at fair value trough P&L 124.539 158.920
1.5. Management fees 2.284 3.200
1.6. Turnover 474 1.288
1.7. Other operating income 5.413 2.779
2. Operating expenses (-) -120.389 -116.145
2.1. Realised losses on disposal of investments -3.832 -3.973
2.2. Unrealised losses on financial assets at fair value through P&L -59.409 -57.227
2.3. Impairment losses -9.456 -12.983
2.4. Purchase of goods and services -15.323 -14.176
2.5. Personnel expenses -20.756 -18.977
2.6. Depreciation of intangible assets -189 -168
2.7. Depreciation of property, plant and equipment -980 -996
2.8. Other operating expenses -10.444 -7.646
3. Operating result, profit (loss) 151.424 150.752
4. Finance income 2.301 2.403
5. Finance cost (-) -573 -611
6. Share of profit (loss) of associates - -
7. Result before tax, profit (loss) 153.151 152.544
8. Tax expenses (-) -3.515 -3.839
9. Net profit (loss) of the period 149.636 148.705
9.1 Non-controlling interests 17.782 11.530
9.2 Attributable to equity holders of the parent 131.853 137.175
Earnings per share (in EUR)
1. Basic earnings per share 5,19 5,39
1bis. Ditto (based on weighted average number of shares) 5,19 5,39
2. Diluted gains earnings per share 5,19 5,39
2bis. Ditto (based on weighted average number of shares) 5,19 5,39
Number of shares at the end of the financial year 25.426.672 25.426.672
Weighted average number of shares of the financial year 25.426.672 25.426.672

Appendix 3: Gimv Group - Statement of changes in consolidated equity for the twelve months to 31 March 2017

Year 2016-2017 Attributable to equity holders of the parent Minority Total
Issued capital Share premium
account
Retained
earnings
Total interest equity
Total 01/04/2016 241.365 51.629 874.894 1.167.888 27.187 1.195.074
2 Net profit (loss) of the period - - 131.853 131.853 17.782 149.635
3. Capital increase - - - - -3.484 -3.484
4. Repayment of capital ( - ) - - - - - -
5. Acquisition/disposal of treasury shares - - -62.295 -62.295 - -62.295
7. Other changes - - -4.268 -4.268 4.259 -9
Total 31/03/2017 241.365 51.629 940.183 1.233.177 45.744 1.278.921
Year 2015-2016 Attributable to equity holders of the parent Total
Share premium
account
Retained
earnings
Total Minority
interest
equity
Total 01/04/2015 241.365 51.629 799.642 1.092.636 18.575 1.111.210
2 Net profit (loss) of the period - - 137.175 137.175 11.530 148.705
3. Capital increase - - - - 742 742
4. Repayment of capital ( - ) - - - - - -
5. Acquisition/disposal of treasury shares - - -62.295 -62.295 - -62.295
7. Other changes - - 372 372 -3.661 -3.289
Total 31/03/2016 241.365 51.629 874.893 1.167.887 27.187 1.195.074

Appendix 4: Gimv Group – Consolidated cash flow statement for the 12 months to 31 March 2017

Gimv Group - Consolidated cash flow statement (in EUR 000) 31/03/2017 31/03/2016
I. Net cash flows from (used in) operating activities (1 + 2) -82.603 -23.504
1. Cash generated from operations (1.1. + 1.2. + 1.3. ) -78.227 -20.237
1.1. Operating result 151.423 150.752
1.2. Adjustment for -211.001 -182.839
1.2.1. Interest income ( - ) -8.209 -10.623
1.2.2. Dividend income ( - ) -42.810 -15.582
1.2.3. Gain on disposal of investments -88.085 -74.506
1.2.4. Losses on disposal of investments 3.832 3.973
1.2.5. Depreciation and amortisation 1.170 1.164
1.2.6. Impairment losses 9.456 12.983
1.2.7.Translation differences - -
1.2.8. Unrealised gains (losses) on financial assets at fair value through P&L -65.131 -101.693
1.2.9. Increase (decrease) in provisions 5.947 4.923
1.2.10. Increase (decrease) pension liabilities (assets) - -
1.2.11. Other adjustments -27.173 -3.479
1.3. Change in working capital -18.649 11.850
1.3.2. Increase (decrease) in trade and other receivables -11.133 5.124
1.3.3. Increase (decrease) in trade and other payables ( - ) -5.481 9.133
1.3.4. Other changes in working capital -2.035 -2.407
2. Income taxes paid (received) -4.375 -3.267
II. Net cash flows from (used in) investing activities (1+2+3+4+5+6+7+8+9+10+11+12+13+14+15+16) 264.302 92.016
1. Purchase of property, plant and equipment ( - ) 577 -526
2. Purchase of investment property (-) - -
3. Purchase of intangible assets ( - ) - -
4. Proceeds from disposal of property, plant and equipment ( + ) - 17
6. Proceeds from disposal of intangible assets ( + ) - -
7. Proceeds from disposal of financial assets at fair value through P&L (+) 359.248 176.904
8. Proceeds from repayment of loans granted to portfolio companies (+) 44.373 22.333
9. Investment in financial assets at fair value through P&L (-) -163.545 -121.623
10. Loans granted to portfolio companies (-) -16.083 -8.597
11. Net investment in other financial assets - -
12. Acquisitions of subsidiaries, associates or joint ventures, net of cash acquired ( - ) - -
13. Interest received 1.625 10.623
14. Dividends received 42.810 15.582
15. Government grants received - -
16. Other cash flows from investing activities -4.701 -2.697
III. Net cash flows from (used in) financing activities (1+2+3+4+5+6+7+8+9+10+11) -60.568 -60.503
1. Proceeds from capital increase - -
2. Proceeds from borrowings - -
4. Proceeds from the sale of treasury shares - -
5. Capital repayment - -
6. Repayment of borrowings ( - ) - -
8. Purchase of treasury shares ( - ) - -
9. Interest paid ( - ) -573 -611
10. Dividends paid ( - ) -62.295 -62.295
11. Other cash flows from financing activities 2.301 2.403
IV. Net increase (decrease) in cash and cash equivalents (I + II + III) 121.132 8.008
V. Cash and cast equivalents at beginning of period 192.774 184.766
VII. Cash and cash equivalents, end of period (I + V + VI) 313.906 192.774